Anebulo Pharmaceuticals, Inc. (ANEB)
Develops an antidote drug for severe cannabis poisoning and overdose.
$0.33+0.10%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-88.4%
The outlook
ANEB is trading near its 52-week lows at $0.33, well below both its 50- and 200-day moving averages, suggesting a downtrend. Analyst coverage appears thin. The overall sentiment reflects weakness, with the stock positioned in the lower part of its annual range.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range10% of the way from its 52-week low to high
Market cap
$13.5M
52-wk high
$3.19
52-wk low
$0.00
50-day avg
$0.39
200-day avg
$1.09
Trailing P/E
—